Sign In

Hwanseok Rhee

(in silico+ in vitro+ in vivo)* genome AI medicine

Professional Background

Hwanseok Rhee is a distinguished scientist and CTO with a wealth of experience in the fields of artificial intelligence, computational biology, and disease genetics. His passion for advancing human health through cutting-edge technology has led him to hold key leadership roles in prominent organizations, primarily focusing on cancer genomics and precision medicine. As the Chief Technology Officer at DNA Link, Hwanseok plays a pivotal role in steering innovation in genetic research and the development of next-generation sequencing technologies.

Rhee's impressive career trajectory includes pivotal positions that showcase his expertise and contributions to the health and biotechnology sectors. He served as the Head of the Cancer Xenograft Center at DNA Link, where he spearheaded research in patient-derived xenografts (PDX) and cancer models, presenting novel frameworks to enhance cancer treatment efficacy. Notably, his leadership in the PDX-based Tissue Biobank for Korean cancer patients stands out, as it provides invaluable resources for researchers working on personalized cancer therapies.

Previously, Hwanseok worked at Macrogen Inc., where he was instrumental in the company's success as the Head of NGS Business and the Chief Information Officer. His work at Macrogen positioned the organization among the global leaders in genomic services, reaffirming his commitment to advancing genetic research on an international scale. Hwanseok's operations oversaw thousands of computing cores and extensive data processing capabilities, emphasizing his exceptional competency in managing large-scale genomic analyses. Rhee's record at Macrogen includes driving the company to achieve sales exceeding 50 million USD worldwide, making it a top-tier player in the genomic service industry.

In addition to his corporate achievements, Hwanseok has made significant contributions to research. His previous studies encompass whole exome and genome sequence analysis for tens of thousands of international samples. These substantial efforts reflect his dedication to understanding diverse genetic factors affecting health and disease, which also aids in the global collaboration on health research initiatives.

Education and Achievements

Hwanseok Rhee's educational background is rich in accomplishments and specialized knowledge. He achieved his Doctor of Philosophy (Ph.D.) in Bioinformatics from Yonsei University, where he honed his skills in harnessing computational techniques for analyzing biological data. Prior to that, he completed his Master of Science (M.Sc.) in Bioinformatics at the same esteemed institution, providing him with a solid foundation in the field. His academic journey began with a Bachelor of Science (B.Sc.) in Molecular Biology from Seoul National University, one of the most respected universities in South Korea. This background set the stage for Hwanseok to thrive in genomic and bioinformatic studies, blending biology with computational science in pursuit of innovative healthcare solutions.

Achievements

Hwanseok Rhee’s contributions and achievements are numerous and impactful, ranging from research initiatives to corporate leadership.

  • Whole Exome and Whole Genome Sequencing: Hwanseok has led pivotal projects involving the analysis of 50,000 whole exomes and 10,000 whole genomes from international samples. These vast studies contribute significantly to our understanding of genetic variations impacting diseases globally.
  • EMR-based DNA Biobank: His initiative for establishing a DNA biobank of 30,000 healthy Koreans has opened avenues for further research into genetic predispositions and population health assessments.
  • AI-driven Anti-Cancer Drug Development: Rhee’s involvement in utilizing artificial intelligence for drug development showcases the innovative methodologies he employs to combat cancer and enhance precision medicine strategies.
  • PXD based Tissue Biobank: The creation of a PDX-based tissue biobank for 1,000 Korean cancer patients illustrates his commitment to developing personalized treatment approaches that consider the unique genetic makeup of individuals.

Hwanseok's leadership in the genome sequencing sector, specifically at DNA Link and Macrogen, where he executed operations as one of the first HiSeq X Ten service providers, has positioned them among the top three global genome sequencing centers and the largest in Korea. His ability to manage extensive computing systems efficiently has contributed to the excellence of genomic research initiatives that drive forward the field of precision medicine.

In summary, Hwanseok Rhee's career exemplifies a compelling blend of scientific research and leading-edge technology applications aimed at enhancing patient health outcomes. With his extensive background in bioinformatics, leadership roles in groundbreaking genomic projects, and pioneering work in cancer research, Hwanseok continues to be an influential figure in the fields of computational biology and genetics. As innovation in healthcare continues to evolve, Hwanseok Rhee remains dedicated to pushing the boundaries of what is possible, advancing precision medicine, and enhancing our understanding of the genetic landscape of disease.

Related Questions

How did Hwanseok Rhee develop his expertise in artificial intelligence and its applications in healthcare?
What are Hwanseok Rhee's current projects focused on DNA, RNA, and PRO?
How has Hwanseok Rhee contributed to the advancement of cancer genomics through his leadership roles?
In what ways has Hwanseok Rhee's education at Yonsei University shaped his career in bioinformatics?
How does Hwanseok Rhee's experience at DNA Link influence his approach to precision medicine?
What innovations did Hwanseok Rhee introduce during his tenure at Macrogen Inc. that impacted genomic research?
How does Hwanseok Rhee's extensive work in sequencing contribute to our understanding of disease genetics?
What are the future implications of Hwanseok Rhee's research on next-generation sequencing and liquid biopsy?
Hwanseok Rhee
Add to my network

Location

South Korea